MEDIZINISCHE HOCHSCHULE HANNOVER [ MHH ]

Carl-Neuberg-Strasse 1 30625 HANNOVER - Germany

Involved in the following projects during the 3rd programme

3rd Health Programme (2014-2020)
Managing Frailty. A comprehensive approach to promote a disability-free advanced age in Europe: the ADVANTAGE initiative [ADVANTAGE]
Managing Frailty. A comprehensive approach to promote a disability-free advanced age: the ADVANTAGE initiative
ADVANTAGE will build a common understanding on frailty to be used by Member States on...
Managing Frailty. A comprehensive approach to promote a disability-free advanced age: the ADVANTAGE initiative
ADVANTAGE will build a common understanding on frailty to be used by Member States on which to base a common management approach of older people who are frail or at risk for developing frailty in the European Union.
The identification of the core components of frailty and its management should promote the needed changes in the organization and the implementation of the Health and Social Systems to provide those models of care that, stemming from the particular health profile of each Member State (MS), will allow them to face the challenge of frailty within a common framework.
ADVANTAGE will summarise the current State of the Art for the different components of frailty and its management, both at individual and population level, will collect information on the development of programs to manage frailty in older adults in the EU and will propose, as its main outcome, a common European model to approach frailty. This model will include a road map that, considering the degree of frailty policies� development, will propose interventions for frail and at risk people and will establish tailored milestones for each MS in order to achieve a comprehensive approach to promote a disability-free advanced age. Furthermore, the model will identify gaps of knowledge in the field that would benefit from further research.
Start date: 01/01/2017 - End date: 31/12/2019
Keywords : [ Ageing ] [ Frailty ] [ Function ]

Call: Health Programme Adhoc Call for invited (named) beneficiaries
Topic: Prevention of frailty
3rd Health Programme (2014-2020)
Promoting Implementation of Recommendations on Policy, Information and Data for Rare Diseases [RD-ACTION]
Rare diseases (RD) have been identified as one of the paradigmatic fields in which actions conducted at the European level constitute the adequate response to their specific problems: poor recognition...
Rare diseases (RD) have been identified as one of the paradigmatic fields in which actions conducted at the European level constitute the adequate response to their specific problems: poor recognition leading to diagnostic delay and inappropriate management including adapted social services, poor health outcomes, social burden, limited knowledge on natural history and pathophysiology leading to an insufficient development of new therapies. The low prevalence and the specificity of RD make that a global, multi-stakeholder approach, intended to gather specific expertise and to build shared strategies is necessary to address these issues.
The general objectives of RD-Action are to:
▪ Support the further development and sustainability of the Orphanet database, the biggest global repository of information on RD
▪ Contribute to solutions to ensure an appropriate codification of RD in health information systems
▪ Continue implementation of the priorities identified in Council Recommendation 2009/C151/02 and the Commission Communication (COM 2008 679) on RD, with a view to ensuring the sustainability of the recommended priority actions and to support the work of the Commission Expert Group on Rare Diseases (CEGRD).
This JA will expand and consolidate the achievements of the former JAs on RD supported by the European Commission: the Orphanet JA and the EUCERD JA. More precisely, this proposal has the ambition to help member states to implement the recommended measures adopted or to be adopted by the CEGRD and to produce the data necessary for countries to do so. Interactions between the production of data at the Orphanet database level and the implementation of policy priorities including codification will be strengthened during this JA.RD-Action large geographical coverage is key to success as it will promote the transfer of European recommendations into national policies and the collection of information and concerns from MS to the CEGRD, thus to the European Commission.

Start date: 01/06/2015 - End date: 31/07/2018

Call: Grants for actions co-financed with Member State authorities 2014 (Joint Actions)
Topic: Rare Disease Joint Action
3rd Health Programme (2014-2020)
Stimulating Innovation Management of Polypharmacy and Adherence in The Elderly [SIMPATHY]
SIMPATHY aims to stimulate, promote and support innovation across the EU in the management of appropriate polypharmacy and adherence in the elderly, in order to contribute to efficient and sustainable...
SIMPATHY aims to stimulate, promote and support innovation across the EU in the management of appropriate polypharmacy and adherence in the elderly, in order to contribute to efficient and sustainable healthcare systems. Through a programme of work and stakeholder engagement we will perform case studies in a range of different healthcare environments, including EIP-AHA reference sites, providing a framework and politico-economic basis for an EU wide benchmarking survey of strategies being employed for polypharmacy and non-adherence management. This includes innovative multidisciplinary models using the professional expertise of pharmacists and physicians to reduce inappropriate polypharmacy and innovation in healthcare workforce development to support patients with long term conditions. A set of contextualised change management approaches and tools will be developed to help politicians, regulators, health service providers, and other stakeholders to improve current practice by implementing organisational change and thus, improve the management of multi-morbid patients. The targeted dissemination of our validated findings and the creation of EU knowledge sharing network on polypharmacy and adherence management will support policy development, implementation of strategic organisational development and exchange of best practice to prepare the ground for necessary change in response to this major challenge. The anticipated outcomes will be a heightened awareness of this growing problem and an impetus for change. Information against which to benchmark regional and national progress, definitive guidance on the role of key stakeholders and how to initiate and manage this change process and will be available for the first time. The final ambition is to secure commitment of high-level political, healthcare providers, commissioners and professional associations to a task-force to address this evident threat to the sustainability of EU healthcare systems.
Start date: 01/06/2015 - End date: 31/05/2017

Call: Call for Proposals for Projects 2014
Topic: Adherence, frailty, integrated care and multi-chronic conditions